Wednesday, February 10, 2010, 2:24pm SGT - The Singapore stock market closes in 2 hours and 36 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Edwards Lifesciences Corp. (EW)

At 5:00AM SGT: 86.65 USD  Down 0.40 (0.46%)  
 MORE ON EW 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 EDWARDS LIFESCIENCES (NYSE:EW) Delayed quote dataEdit
After Hours: 86.65 0.00 (0.00%) as of 5:31am SGT on 02/10/10
Last Trade:86.65 USD
Trade Time:5:00AM SGT
Change:Down 0.40 (0.46%)
Prev Close:87.05
Open:88.00
Bid:N/A
Ask:N/A
1y Target Est:93.43
Day's Range:85.61 - 88.25
52wk Range:52.86 - 94.55
Volume:725,056
Avg Vol (3m):337,676
Market Cap:4.90B
P/E (ttm):23.08
EPS (ttm):3.76
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add EW to Portfolio   Download Data

 HEADLINES 
•New Star Analyst Rankings for EDWARDS LIFESCIENCES
StarMine (Sun, Feb 7)
•New Device Promises To Make Heart Surgery Easier And Safer
Investor's Business Daily (Sat, Feb 6)
•Edwards Lifesciences Corp. Q4 2009 Earnings Call Transcript
at Seeking Alpha (Fri, Feb 5)
•UPDATE - Edwards 4th-quarter profit rises 25 percent
at Reuters (Fri, Feb 5)
•Earnings roundup: Power-One, FIS
AP (Fri, Feb 5)
•Edwards Lifesciences 4Q profit rises 25 percent
AP (Fri, Feb 5)
•EDWARDS LIFESCIENCES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Fri, Feb 5)
•Edwards Lifesciences Reports Strong Fourth Quarter Results
Marketwire (Fri, Feb 5)
•Q4 2009 Edwards Lifesciences Earnings Release - Time Not Supplied
CCBN (Thu, Feb 4)
•Five Mid-Cap Stocks Ready to Break Out
at TheStreet.com (Thu, Feb 4)
More Headlines for EW...
 ANALYST 
EPS Est (next year) (Dec-09) :3.05
EPS Est (in 2 years) (Dec-10) :3.55
Avg Rec (current)*:2.3
PEG Ratio:1.69
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Edwards Lifesciences Corporation provides products and technologies designed to treat cardiovascular diseases. It provides products and technologies for heart valve therapy, critical care, cardiac surgery systems, and vascular disease.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices